Showing results (81-90 of 339) with videos related to
Sort By:
Pageof 34
Transplantation and Cellular Therapy|September 19, 2021
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and OutcomesNosha Farhadfar, Helen L Leather, Shu Wang, et al.Blood Advances|September 1, 2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1Celalettin Ustun, Soyoung Kim, Min Chen, et al.Vaccine|September 10, 2018
Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectivesIbrahim N Muhsen, Mahmoud Aljurf, John R Wingard, et al.Stem Cells (Dayton, Ohio)|July 28, 2007
The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplantWilliam B Slayton, Xiao-Miao Li, Jason Butler, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipientsM Hong Nguyen, Helen Leather, Cornelius J Clancy, et al.Transplantation and Cellular Therapy|April 25, 2021
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes ForumJohn R Wingard, Kwang Woo Ahn, Christopher Dandoy, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 14, 2007
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic feverJohn R Wingard, Helen L Leather, Craig A Wood, et al.Blood Neoplasia|July 30, 2025
Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCTErin A Dean, Arkaprava Roy, Rick Y Lin, et al.Blood|April 24, 2015
Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cellsNancy Y Villa, Clive H Wasserfall, Amy M Meacham, et al.American Journal of Hematology|June 27, 2003
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myelomaChristopher R Cogle, Jan S Moreb, Helen L Leather, et al.Pageof 34